Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials, The Lancet, vol.377, issue.9779, pp.1760-176905, 2011. ,
DOI : 10.1016/S0140-6736(11)60405-4
URL : https://hal.archives-ouvertes.fr/hal-00873255
Interstitial lung disease in connective tissue disorders, The Lancet, vol.380, issue.9842, pp.689-698 ,
DOI : 10.1016/S0140-6736(12)61079-4
The Pulmonary Fibrosis-Associated MUC5B Promoter Polymorphism Does Not Influence the Development of Interstitial Pneumonia in Systemic Sclerosis, Chest, vol.142, issue.6, p.5, 2012. ,
DOI : 10.1378/chest.12-0110
Fibrocytes and the tissue niche in lung repair, Respiratory Research, vol.8, issue.1, p.76, 2011. ,
DOI : 10.1096/fj.05-4682rev
Pulmonary fibrosis: patterns and perpetrators, Journal of Clinical Investigation, vol.122, issue.8, pp.2756-62 ,
DOI : 10.1172/JCI60323
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408732
Defect of Pro-Hepatocyte Growth Factor Activation by Fibroblasts in Idiopathic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.1, pp.58-6601, 2006. ,
DOI : 10.1164/rccm.200507-1074OC
Idiopathic pulmonary fibrosis, The Lancet, vol.378, issue.9807, pp.1949-6102, 2011. ,
DOI : 10.1016/S0140-6736(11)60052-4
URL : https://hal.archives-ouvertes.fr/hal-00873255
Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype, Respiratory Research, vol.13, issue.1, p.74, 2012. ,
DOI : 10.1016/S0002-9440(10)63330-5
MicroRNAs in idiopathic pulmonary fibrosis, Translational Res J Lab Clin Med, vol.15723, issue.4, pp.191-200, 2011. ,
Microarray profile reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease, Respir Res, 2013. ,
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway, Annals of the Rheumatic Diseases, vol.70, issue.11 ,
DOI : 10.1136/ard.2011.150326
Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial, British Journal of Dermatology, vol.38, issue.9, pp.639-687, 1998. ,
DOI : 10.1006/clin.1996.0118
Feasibility of a trial of interferon-beta1A in the treatment of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, vol.163, p.707, 2001. ,
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial, The Lancet, vol.374, issue.9685, pp.222-80703, 2009. ,
DOI : 10.1016/S0140-6736(09)60551-1
Delivery and safety of inhaled interferon-gamma in idiopathic pulmonary fibrosis, J Aerosol Med Pulm Drug Deliv, vol.2012, issue.252, pp.79-87 ,
High-throughput sequencing for biology and medicine, Molecular Systems Biology, vol.759, issue.1, p.640 ,
DOI : 10.1038/ng1891